Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The peptidoglycan of Staphylococcus aureus is a thick, highly cross-linked polymer that forms the major structural component of its cell wall. It provides mechanical strength, maintains cellular integrity, and serves as a scaffold for the attachment of surface proteins and extracellular matrices essential for cell morphogenesis, division, and pathogenesis. It is composed of glycan chains (GlcNAc-MurNAc), pentapeptide stems, and pentaglycine bridges. Peptidoglycan synthesis is targeted by several crucial antibiotics (e.g., β-lactams), which inhibit transpeptidase activity required for cross-linking. Disruption leads to loss of cell wall integrity and bacterial death. Peptidoglycan fragments can also trigger host immune responses.
Inhibition of transpeptidase activity, leading to disruption of peptidoglycan cross-linking and cell wall integrity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Staphylococcus aureus Cell Wall Peptidoglycan (Peptidoglycan).